These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 7742427)
1. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period. de Lalla F; Pellizzer G; Vaglia A; Manfrin V; Franzetti M; Fabris P; Stecca C Clin Infect Dis; 1995 Feb; 20(2):263-6. PubMed ID: 7742427 [TBL] [Abstract][Full Text] [Related]
2. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426 [TBL] [Abstract][Full Text] [Related]
3. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236 [TBL] [Abstract][Full Text] [Related]
4. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. Nelson MR; Fisher M; Cartledge J; Rogers T; Gazzard BG AIDS; 1994 May; 8(5):651-4. PubMed ID: 8060545 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis. Parisi A; Malfitano A; Bruno R; Calderon W; Sacchi P; Patruno SF; Filice G Mycoses; 1997 Oct; 40(5-6):203-7. PubMed ID: 9476489 [TBL] [Abstract][Full Text] [Related]
6. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Larsen RA; Leal MA; Chan LS Ann Intern Med; 1990 Aug; 113(3):183-7. PubMed ID: 2197908 [TBL] [Abstract][Full Text] [Related]
7. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722 [TBL] [Abstract][Full Text] [Related]
8. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS. Jaruratanasirikul S Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):719-23. PubMed ID: 9253873 [TBL] [Abstract][Full Text] [Related]
9. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses over a relatively short period. Churchill D; Coker R Clin Infect Dis; 1995 Nov; 21(5):1352-3. PubMed ID: 8589187 [No Abstract] [Full Text] [Related]
10. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment. Gupta C; Dogra P; Jain V; Kaur R; Sharma JB Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558 [TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis. Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068 [TBL] [Abstract][Full Text] [Related]
12. Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Sugar AM; Saunders C Am J Med; 1988 Oct; 85(4):481-9. PubMed ID: 2845779 [TBL] [Abstract][Full Text] [Related]
13. Therapy for cryptococcal meningitis in patients with AIDS. Powderly WG Clin Infect Dis; 1992 Mar; 14 Suppl 1():S54-9. PubMed ID: 1562696 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome]. Graybill JR Rev Clin Esp; 1995 Oct; 195 Suppl 3():26-30. PubMed ID: 9441302 [No Abstract] [Full Text] [Related]
15. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients. Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072 [TBL] [Abstract][Full Text] [Related]
16. Current approach to the acute management of cryptococcal infections. Powderly WG J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709 [No Abstract] [Full Text] [Related]
17. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774 [TBL] [Abstract][Full Text] [Related]
18. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. de Gans J; Portegies P; Tiessens G; Eeftinck Schattenkerk JK; van Boxtel CJ; van Ketel RJ; Stam J AIDS; 1992 Feb; 6(2):185-90. PubMed ID: 1313682 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study Group. Dromer F; Mathoulin S; Dupont B; Brugiere O; Letenneur L Clin Infect Dis; 1996 May; 22 Suppl 2():S154-60. PubMed ID: 8722844 [TBL] [Abstract][Full Text] [Related]
20. Cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. Zeind CS; Cleveland KO; Menon M; Brown JR; Solomon DK Pharmacotherapy; 1996; 16(4):547-61. PubMed ID: 8840361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]